Skip to content

DMA Amylase (Demand) Procedure

by Data Medical Associates, Inc. 510(k)

Active United States

510(k) K940010

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK940010 Date11 Mar 1994ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CIJ
Device Class
Class II
Regulation
21 CFR Part 862.1070
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The DMA Amylase (Demand) Procedure is a saccharogenic amylase device used in clinical chemistry. It is classified as a Class II medical device under regulation number 862.1070.

The device received FDA 510(k) clearance (K940010) on March 11, 1994, following a traditional review process. It was found substantially equivalent to a predicate device and is manufactured by Data Medical Associates, Inc. The product code is CIJ, and it falls under the clinical chemistry medical specialty.

Other devices from Data Medical Associates, Inc.

See all devices from Data Medical Associates, Inc. →

Questions

AI-generated answers, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the DMA Amylase (Demand) Procedure used for?

    The DMA Amylase (Demand) Procedure is a saccharogenic amylase device used in clinical chemistry to measure amylase enzyme activity, which aids in diagnosing conditions such as pancreatitis or salivary gland disorders by detecting elevated levels in biological fluids.

  • How is the DMA Amylase (Demand) Procedure supplied and is it sterile or single-use?

    The device data does not specify supply format, sterility, or single-use/reuse status; therefore, no details about packaging, sterilization method, or intended use duration can be confirmed from the provided information.

  • What regulatory pathway was used for the DMA Amylase (Demand) Procedure and when was it cleared?

    The DMA Amylase (Demand) Procedure received FDA 510(k) clearance through a traditional review process on March 11, 1994, under K940010, after being determined substantially equivalent to a legally marketed predicate device.